Business, energy, technology, markets and global industry news from Business News Today

Skip to content

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

refractive cataract surgery

PharmaDeviceNews refractive cataract surgery

Representative image of an intraocular lens procedure, illustrating how Alcon’s Clareon TruPlus launch could intensify competition in enhanced monofocal cataract lenses at ASCRS 2026.

Medical Devices & Diagnostics

Is Alcon redefining the enhanced monofocal category with Clareon TruPlus at ASCRS 2026?

by Pallavi Madhiraju
April 7, 2026
0 Comments

Alcon launched Clareon TruPlus at ASCRS 2026. Read why the new enhanced monofocal IOL could reshape cataract lens choice.

Read More

Latest news and features

Innoviva’s antibiotics are growing 45%, so why did the company report a $73.9m loss?
Summit Therapeutics has $2bn from AstraZeneca and stronger cancer survival data, but will the FDA approve ivonescimab?
Evommune bets $30m on a VAV1 degrader that could challenge JAK inhibitors, but can it deliver safer autoimmune treatment?
Iadademstat shows 95% response rate in leukemia as Oryzon Genomics prepares Phase 3 development
FDA grants breakthrough designation to daridorexant following 50-minute sleep improvement in children
Pelareorep shows promising HPV-targeted immune activity as Oncolytics Biotech advances cancer research
Annamycin leukemia trial progresses toward pivotal dose selection after encouraging interim results
Kairos Pharma highlights 17.7-month progression-free survival with ENV-105 combination in metastatic prostate cancer
Bayer’s asundexian cut recurrent stroke risk by 26%, but can new AHA evidence strengthen its global approval prospects?
Imperative Care reports comparable 30-day outcomes for women and men in 106-patient pulmonary embolism analysis
EVX-01 personalized cancer vaccine moves into focus as Evaxion examines broader immune responses
PAS-004 advances toward Phase 2 as Pasithea seeks new treatment approach for cutaneous neurofibromas

POPULAR NEWS

plated Skin Science’s new BODY Serum brings platelet-derived exosome skincare beyond the face, targeting signs of aging, texture and hydration across the body. Representative image.

Pharma & Biotech

Rion Aesthetics expands plated Skin Science exosome platform with $338 BODY Serum

August 19, 2026

Pharma & Biotech

Omabit raises $2m to connect fragmented clinical evidence, but can AI improve drug development decisions?

October 27, 2026

Medical Devices & Diagnostics

Presage Technologies SmartSpectra cleared for contactless vital signs monitoring

July 8, 2026

Latest business and industry news

Agilent completes $240m Proscia acquisition to expand AI-enabled pathology
Thomson Reuters revenue rises 10%, so why did TRI fall 7% on its AI strategy?
Thames Water names nine teams for £4bn projects framework as debt talks continue
Japan launches National Disaster Management Agency as megaquake threat looms
Boeing wins $119.7m P-8A upgrade order as defence margins remain under pressure

TAGS

AstraZeneca clinical trials Eli Lilly and Company European Medicines Agency FDA FDA approval immunotherapy Inc. Johnson & Johnson medical devices non-small cell lung cancer oncology precision oncology U.S. Food and Drug Administration United States Food and Drug Administration

About PharmaDeviceNews
Disclaimer
Editorial Policy
Privacy Policy
Contact Us

© 2026 PharmaDeviceNews.com. All rights reserved.